Genedx Holdings [WGS] vs Thermo Fisher [TMO] Detailed Stock Comparison
Genedx Holdings
NASDAQ
Loading...
Thermo Fisher
NYSE
Loading...
TLDR: Quick Comparison Summary
Based on 20 vital metrics comparison: Genedx Holdings wins in 4 metrics, Thermo Fisher wins in 15 metrics, with 0 ties. Thermo Fisher appears stronger overall.
View Metrics Details
Vital Metrics Comparison
| Metric | Genedx Holdings | Thermo Fisher | Better |
|---|---|---|---|
| P/E Ratio (TTM) | 1,507.81 | 28.25 | Thermo Fisher |
| Price-to-Book Ratio | 12.50 | 3.66 | Thermo Fisher |
| Debt-to-Equity Ratio | 41.27 | 69.62 | Genedx Holdings |
| PEG Ratio | -11.21 | 4.97 | Genedx Holdings |
| EV/EBITDA | 112.31 | 19.74 | Thermo Fisher |
| Profit Margin (TTM) | 0.39% | 15.24% | Thermo Fisher |
| Operating Margin (TTM) | 8.73% | 17.84% | Thermo Fisher |
| EBITDA Margin (TTM) | 8.73% | 17.84% | Thermo Fisher |
| Return on Equity | 0.60% | 13.42% | Thermo Fisher |
| Return on Assets (TTM) | 1.05% | 4.97% | Thermo Fisher |
| Free Cash Flow (TTM) | $-33.99M | $7.27B | Thermo Fisher |
| Dividend Yield | N/A | 0.31% | N/A |
| 1-Year Return | 265.52% | -19.04% | Genedx Holdings |
| Price-to-Sales Ratio (TTM) | 9.56 | 4.27 | Thermo Fisher |
| Enterprise Value | $3.32B | $213.59B | Thermo Fisher |
| EV/Revenue Ratio | 9.17 | 4.94 | Thermo Fisher |
| Gross Profit Margin (TTM) | 69.04% | 40.61% | Genedx Holdings |
| Revenue per Share (TTM) | $13 | $114 | Thermo Fisher |
| Earnings per Share (Diluted) | $0.08 | $17.31 | Thermo Fisher |
| Beta (Stock Volatility) | 2.08 | 0.75 | Thermo Fisher |
Performance
Key Stats
Valuation
Financials
Short Interest
Dividends
Genedx Holdings vs Thermo Fisher Stock Performance Analysis
Loading Price Chart...
Performance Comparison
Short-term Returns
| Stock | 1D | 1W | 1M | 3M | 6M | YTD |
|---|---|---|---|---|---|---|
| Genedx Holdings | 2.83% | 20.19% | 54.68% | 98.65% | 12.06% | 58.68% |
| Thermo Fisher | 0.82% | 6.14% | 16.99% | 20.76% | -6.52% | -6.42% |
Long-term Returns
| Stock | 1Y | 3Y | 5Y | 10Y | 15Y | 20Y |
|---|---|---|---|---|---|---|
| Genedx Holdings | 265.52% | 221.77% | 1,189.39% | 1,189.39% | 1,189.39% | 1,189.39% |
| Thermo Fisher | -19.04% | -16.91% | 14.10% | 282.16% | 1,006.36% | 1,621.87% |
Performance & Financial Health Analysis: Genedx Holdings vs Thermo Fisher
| Metric | WGS | TMO |
|---|---|---|
| Market Information | ||
| Market Cap | $3.47B | $184.66B |
| Market Cap Category | Mid cap | Large cap |
| 10 Day Avg. Volume | 695,061 | 2,008,780 |
| 90 Day Avg. Volume | 865,664 | 2,910,363 |
| Last Close | $126.36 | $489.01 |
| 52 Week Range | $28.86 - $127.36 | $385.46 - $627.88 |
| % from 52W High | -0.78% | -22.12% |
| All-Time High | $417.42 (Aug 09, 2021) | $672.34 (Dec 27, 2021) |
| % from All-Time High | -69.73% | -27.27% |
| Growth Metrics | ||
| Quarterly Revenue Growth | 0.46% | 0.03% |
| Quarterly Earnings Growth | 0.46% | 0.05% |
| Financial Health | ||
| Profit Margin (TTM) | 0.00% | 0.15% |
| Operating Margin (TTM) | 0.09% | 0.18% |
| Return on Equity (TTM) | 0.01% | 0.13% |
| Debt to Equity (MRQ) | 41.27 | 69.62 |
| Cash & Liquidity | ||
| Book Value per Share (MRQ) | $9.65 | $133.77 |
| Cash per Share (MRQ) | $4.68 | $16.92 |
| Operating Cash Flow (TTM) | $13.02M | $7.58B |
| Levered Free Cash Flow (TTM) | $20.21M | $5.18B |
| Dividends | ||
| Last 12-Month Dividend Yield | N/A | 0.31% |
| Last 12-Month Dividend | N/A | $1.21 |
Valuation & Enterprise Metrics Analysis: Genedx Holdings vs Thermo Fisher
| Metric | WGS | TMO |
|---|---|---|
| Price Ratios | ||
| P/E Ratio (TTM) | 1,507.81 | 28.25 |
| Forward P/E | 246.17 | 20.82 |
| PEG Ratio | -11.21 | 4.97 |
| Price to Sales (TTM) | 9.56 | 4.27 |
| Price to Book (MRQ) | 12.50 | 3.66 |
| Market Capitalization | ||
| Market Capitalization | $3.47B | $184.66B |
| Enterprise Value | $3.32B | $213.59B |
| Enterprise Value Metrics | ||
| Enterprise to Revenue | 9.17 | 4.94 |
| Enterprise to EBITDA | 112.31 | 19.74 |
| Risk & Other Metrics | ||
| Beta | 2.08 | 0.75 |
| Book Value per Share (MRQ) | $9.65 | $133.77 |
Financial Statements Comparison: Genedx Holdings vs Thermo Fisher
Financial Metrics
Loading Financial Charts...
Revenue
EBITDA
Operating Margin
Free Cash Flow
Long Term Debt
Profit Margin
Current Ratio
Operating Cash Flow
Income Statement (MRQ)
| Metric (MRQ) | WGS | TMO |
|---|---|---|
| Revenue/Sales | $102.69M | $10.36B |
| Cost of Goods Sold | $31.79M | $6.13B |
| Gross Profit | $70.90M | $4.24B |
| Research & Development | $14.87M | $342.00M |
| Operating Income (EBIT) | $8.96M | $1.82B |
| EBITDA | $15.39M | $2.73B |
| Pre-Tax Income | $10.56M | $1.62B |
| Income Tax | $-246,000 | $95.00M |
| Net Income (Profit) | $10.81M | $1.51B |
Balance Sheet & Liquidity Metrics (MRQ)
| Metric (MRQ) | WGS | TMO |
|---|---|---|
| Cash & Equivalents | $99.70M | $4.13B |
| Total Current Assets | $225.82M | $23.38B |
| Total Current Liabilities | $69.54M | $13.17B |
| Long-Term Debt | $111.71M | $31.37B |
| Total Shareholders Equity | $257.41M | $49.49B |
| Retained Earnings | $-1.36B | $54.45B |
| Property, Plant & Equipment | $51.39M | N/A |
Cash Flow Statement Comparison (MRQ)
| Metric (MRQ) | WGS | TMO |
|---|---|---|
| Operating Cash Flow | $-1.74M | $2.15B |
| Capital Expenditures | $-6.13M | $-350.00M |
| Free Cash Flow | $4.05M | $361.00M |
| Debt Repayment | $-911,000 | $-838.00M |
| Common Stock Repurchase | N/A | $-2.00B |
Short Interest & Institutional Ownership Analysis
| Metric | WGS | TMO |
|---|---|---|
| Shares Short | 3.64M | 3.71M |
| Short Ratio | 3.87 | 1.14 |
| Short % of Float | 0.25% | 0.01% |
| Average Daily Volume (10 Day) | 695,061 | 2,008,780 |
| Average Daily Volume (90 Day) | 865,664 | 2,910,363 |
| Shares Outstanding | 28.02M | 380.77M |
| Float Shares | 19.64M | 376.76M |
| % Held by Insiders | 0.12% | 0.00% |
| % Held by Institutions | 1.08% | 0.92% |
Dividend Analysis & Yield Comparison: Genedx Holdings vs Thermo Fisher
| Metric | WGS | TMO |
|---|---|---|
| Last 12-Month Dividend | N/A | $1.21 |
| Last 12-Month Dividend Yield | N/A | 0.31% |
| 3-Year Avg Annual Dividend | N/A | $1.33 |
| 3-Year Avg Dividend Yield | N/A | 0.07% |
| 3-Year Total Dividends | N/A | $3.99 |
| Ex-Dividend Date | N/A | Mar 14, 2025 |